期刊文献+

表柔比星与羟基喜树碱交替灌注预防膀胱癌术后复发 被引量:3

下载PDF
导出
出处 《河北医学》 CAS 2004年第3期271-272,共2页 Hebei Medicine
  • 相关文献

参考文献10

  • 1程鸿鸣,陈宗福,李虹,张卫东,张思孝.羟基喜树碱灌注预防膀胱癌术后复发(附86例报告)[J].临床泌尿外科杂志,2000,15(2):62-63. 被引量:25
  • 2刘本春.表阿霉素在膀胱癌治疗及复发预防中的应用[J].中国癌症杂志,1998,8(3):232-234. 被引量:17
  • 3kaisay AV. Intravesicai BCG therapy in the management of multipie superficial bladdr carcinoma: comparison between Glaxo and Pasteur stralns[J]. Br J Urol, 1987,59:554.
  • 4Jenniings AM, Solomon LI, Sharp P, et al. Estaanustine reversal of resistance to intravesical epirubicin chemotherapy [ J ]. Earllrol, 1999,35(4) :327 - 335.
  • 5Kondo T, Onitsuka S, Ryojio, et al. Analysis of prognosticfactors related torimary superficial bladder cancer tumor recurrence in prophylactic intrauesicul epirubicin therapy [ J ]. Int J Urol, 1999,6(4) : 178 - 183.
  • 6刘本春,张元芳,王忠,丁强.BTA检测在膀胱癌诊断中的价值[J].中国癌症杂志,1998,8(4):292-294. 被引量:1
  • 7王羲明.羟基喜树碱的抗癌机理和临床[J].中国肿瘤临床,1999,10(3):7-9.
  • 8kaisay AV.Intravesicai BCG therapy in the management of multiple superficial bladdr carcinoma:comparison between Glaxo and Pasteur strains[J].Br J Urol,1987,59:554.
  • 9Jenniings AM,Solomon LI,Sharp P, et al.Estranustine reversal of resistance to intravesical epirubicin chemotherapy[J].Earllrol, 1999,35(4):327-335.
  • 10Kondo T, Onitsuka S, Ryojio, et al. Analysis of prognosticfactors related torimary superficial bladder cancer tumor recurrence in prophylactic intrauesicul epirubicin therapy[J].Int J Urol,1999,6(4):178-183.

二级参考文献32

  • 1张思孝,李虹,程鸿鸣,张卫东,卢一平,陈宗福,杨宇如.膀胱内灌注疗法预防膀胱癌术后复发的效果[J].中华外科杂志,1995,33(5):304-306. 被引量:9
  • 2王羲明.羟基喜树碱的抗癌机理和临床[J].中国肿瘤临床,1997,10:7-7.
  • 3胥彬.羟基喜树碱(HCPT)及有关同型物的研究进展[J].中国肿瘤临床,1997,10:6-8.
  • 4Lamm DL. Prophylaxis for recurrent transitional cell carcinoma. Urology,1991,37(suppl 5):21.
  • 5Nakagawa S, Kojima M, Nakao M, et al. Fluorescence,microscopic study on absorption of adriamycin through the rat bladder epithelium. Tohoku J Exp Med,1987,153: 227.
  • 6Matamura Y, Tsushima T O zaki Y , et al ,Intravesical chemotherapy with 4'-epi-adriamycin in patients with superficial bladder tumours. Cancer Chemother Pharmacol, 1986,16.
  • 7Calais da Silva F.Denis L,Bono A.et al. Intravesical chemoresection with 4`-epidoxorubicin in patients with superficial bladder tumours. Eur Urol, 1988,4 : 207.
  • 8Cumming, JA, Kirk D, Newling DW, et al. A multicentre phase I study of intravesical epirubicin in the treatment of superficial bladder turnout. Eur Urol,1990,17:20.
  • 9Popert RJM, Goodall J, Coptcoat M J, et al Superficial bladder cancer:the response of a marker tumour to a single intravesical instillation of epirubicin. Br d Uro1,1994,195.
  • 10Skarlos DV, Aravantinos G, Linardou E, et al Chemotherapy with methotrexate,vinblastine,epirubicin and carboplatin (Carbo-MVE) in transitional cell urotheliat canter. A Hellenic Co-Operative Oncology Group Study. Eur Urol, 1997,31 : 470.

共引文献40

同被引文献18

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部